Tag:

Prevnar-13

Latest Headlines

Latest Headlines

Vaccine proves widely effective against meningitis

January 15, 2009 | By
Over the past eight years a vaccine that guards against pneumococcal meningitis has slashed the number of new cases posted for children under the age of two. In a new study published in the New

Wyeth ready to bring Prevnar to EU market

December 3, 2008 | By
Although the company said it expected to file its regulatory applications in the U.S. and Europe next year, Wyeth announced Wednesday that it had submitted it's application to the EMEA for Prevnar-13

Wyeth's PCV vax better than current blockbuster

October 27, 2008 | By
Wyeth's investigational pneumococcal vaccine (PCV) for young children, Prevnar-13, appears to offer better protection than the current blockbuster vaccine, Prevnar. The New Jersey-based company

Wyeth seeking regulatory approval for Prevnar-13

October 9, 2008 | By
Wyeth is putting the finishing touches on its regulatory application for Prevnar-13, the latest generation in a series of jabs that defend against pneumococcal disease. Wyeth researchers say that
Related Tags
Press Releases
  • Addition of VX-661 to KALYDECO® (ivacaftor) Improves Lung Function in People with CF Who Are Heterozygous for the F508del and G551D Mutations in 28-day Phase 2 Proof-of-Concept Study
  • NEW EXPERIMENTAL VACCINE PRODUCES IMMUNE RESPONSE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV)
  • Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations
  • Quintiles Reports First Quarter 2014 Results
  • Novartis announces presentation of data at AAN showing Gilenya® slowed the rate of brain volume loss in MS patients
  • More Press Releases
Featured Jobs
Sponsored Links